Alnylam Pharmaceuticals, Inc.

NORGES BANK ALNY
Report date
12/31/2025
Quarter
2025 Q4
Filed
2/10/2026
Shares
2,252,775
Value ($000)
895,816
Weight
0.1%
2013 Q1 - 2025 Q4 (11 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).